Correlation Between Bionoid Pharma and BC Bud
Can any of the company-specific risk be diversified away by investing in both Bionoid Pharma and BC Bud at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionoid Pharma and BC Bud into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionoid Pharma and The BC Bud, you can compare the effects of market volatilities on Bionoid Pharma and BC Bud and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionoid Pharma with a short position of BC Bud. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionoid Pharma and BC Bud.
Diversification Opportunities for Bionoid Pharma and BC Bud
0.42 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bionoid and BCBCF is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Bionoid Pharma and The BC Bud in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BC Bud and Bionoid Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionoid Pharma are associated (or correlated) with BC Bud. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BC Bud has no effect on the direction of Bionoid Pharma i.e., Bionoid Pharma and BC Bud go up and down completely randomly.
Pair Corralation between Bionoid Pharma and BC Bud
Given the investment horizon of 90 days Bionoid Pharma is expected to generate 2.16 times more return on investment than BC Bud. However, Bionoid Pharma is 2.16 times more volatile than The BC Bud. It trades about 0.06 of its potential returns per unit of risk. The BC Bud is currently generating about 0.05 per unit of risk. If you would invest 100.00 in Bionoid Pharma on November 2, 2024 and sell it today you would lose (72.00) from holding Bionoid Pharma or give up 72.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bionoid Pharma vs. The BC Bud
Performance |
| Timeline |
| Bionoid Pharma |
| BC Bud |
Bionoid Pharma and BC Bud Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bionoid Pharma and BC Bud
The main advantage of trading using opposite Bionoid Pharma and BC Bud positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionoid Pharma position performs unexpectedly, BC Bud can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BC Bud will offset losses from the drop in BC Bud's long position.| Bionoid Pharma vs. Weibo Corp | Bionoid Pharma vs. Tandem Diabetes Care | Bionoid Pharma vs. Cardinal Health | Bionoid Pharma vs. Space Communication |
| BC Bud vs. Amexdrug | BC Bud vs. Crescita Therapeutics | BC Bud vs. Aion Therapeutic | BC Bud vs. Alterola Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |